跳至主要内容
临床试验/NCT01137539
NCT01137539已完成不适用

TVT-SECUR as an Office-based Procedure - A Pilot Study

Michigan Institution of Women's Health PC2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2008年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
2
主要终点
Treatment Success Based on Patient Report on Validated Questionnaire

研究概览

简要总结

This is a pilot study to assess the feasibility and success of performing the TVT-Secur in the office setting. Endpoints would be success, complications, and patient and physician acceptance of the procedure. Success would be assessed by validated questionnaires.

This is a prospective single arm study of 50 patients who will have the TVT-Secur procedure done in the office under local anesthesia. They will be followed for a period of 3 years.

详细描述

The study will include 50 patients who would meet the inclusion/exclusion criteria and who sign the informed consent. Subjects are diagnosed with Stress urinary incontinence resulting from urethral hypermobility with no prior urinary incontinence surgery. Subjects are women who no longer intend to bear children and who do not require any other concomitant surgery.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 89 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Stress urinary incontinence with hypermobility of the UV junction
  • ASA I or II
  • Age 21-89

排除标准

  • Prior anti-incontinence surgery
  • Not completed childbearing
  • ASA III or higher
  • Need concomitant surgery
  • Poor compliance for office based approach

结局指标

主要结局

Treatment Success Based on Patient Report on Validated Questionnaire

时间窗: 24 months

Negative response to question #3 on the Urogenital Distress Inventory-6 (UDI-6) questionnaire. Question #3 states, "Do you currently experience urine leakage related to physical activity, coughing or sneezing." If a subject answers "No", this is considered success. If a subject answers "Yes", this is considered failure of treatment.

次要结局

  • Patient Satisfaction(12 months)

研究者

发起方
Michigan Institution of Women's Health PC
申办方类型
Other
责任方
Principal Investigator
主要研究者

Salil Khandwala MD

President, Michigan Institution of Women's Health PC

Michigan Institution of Women's Health PC

研究点 (2)

Loading locations...

相似试验